Axinn Represents Thermo Fisher in $1.3B Acquisition of Affymetrix
January 11, 2016
Axinn is representing Thermo Fisher Scientific Inc. in its $1.3 billion acquisition of Affymetrix, a leading provider of cellular and genetic analysis products. The Axinn team consists of John Harkrider, Mark Alexander and Kail Jethmalani.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Consumer Brands CPG Legal Forum 2026
Speaking Engagement
NBA CLS 39th Annual Corporate Counsel Conference
Sponsorship
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
GCR Live Global: Navigating the Future of Antitrust 2026
Speaking Engagement
Antitrust
Why Should I Care About Property Controls?
Speaking Engagement
Antitrust
What’s the Score, Your Honor? Conversation With Judge Richard Boulware
Podcast
LCA Renaissance Symposium XIX 2025
Speaking Engagement
Antitrust
Stakeholders 25th Annual CYOC Career Development Conference
Sponsorship
Antitrust
Japan Competition Law Update
Axinn Viewpoints
Antitrust
California's Crackdown on Algorithmic Pricing
Axinn Viewpoints
Antitrust